Primary Dysmenorrhea
Conditions
Interventions
Experimental group:One week before menstruation and 3 days before menstruation take Guizhi Fuling pill decoction 3g 10 consecutive days per menstrual cycle for 3 consecutive menstrual cycles.
Control group:The use of malt (stir-fried) and grain bud (stir-fried) without similar effects, the packaging and grams are consistent with the test group. One week before menstruation and 3 days befor
Sponsors
Yichang maternal and child Health care Hospital
Eligibility
Sex/Gender
Female
Age
15 Years to 35 Years
Inclusion criteria
Inclusion criteria: Experimental group: (1) Meet the diagnostic criteria of PD and cold coagulation and blood stasis syndrome; (2) Age 15-35 years old; (3) Menstrual cycle (28±7) days; (4) did not receive any other treatment in the 1 menstrual cycle before this therapy and did not take sedatives analgesics hormones within 2 weeks before treatment; (5) Sign informed consent and voluntarily participate in this study. Note: Patients who meet the above 5 criteria at the same time can be included in this study. Control group: (1) 18 years old =30 years old; (2) The menstrual cycle is basically normal (28±7 days); (3) Physical examination of various physiological indicators in the normal range no functional or organic diseases; (4) no family history of mental and nervous system; (5) The subjects themselves sign the paper informed consent and volunteer to participate in the experiment. Note: Only healthy subjects who meet all of the above inclusion criteria can be included in this study.
Exclusion criteria
Exclusion criteria: Experimental group: If any of the following meets the criteria the patient will not be admitted to the study: (1) Patients with secondary dysmenorrhea such as uterine fibroids adenomyosis endometriosis and pelvic inflammatory disease were examined; (2) Women in preparation for pregnancy pregnancy and breastfeeding; (3) is using a drug with similar effects to the test drug; (4) Patients with a history of low back pain; (5) Patients with serious primary diseases such as cardiovascular cerebrovascular liver kidney and hematopoietic system; (6) Have mental disorders and mental disorders can not cooperate with the questionnaire investigator; (7) Participants in multiple clinical subjects at the same time; (8) Patients who refuse to sign informed consent. Control group: (1) Pregnant or lactating women within half a year of fertility requirements; (2) long-term users of analgesics and those with alcohol dependence or drug abuse. Note: Healthy subjects who meet any of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-Rating Anxiety Scale;Cox Menstrual Symptom Scale;Self-rating depression Scale;Uterine artery blood flow index;Traditional Chinese Medicine Syndrome Score; | — |
Countries
China
Contacts
Public ContactYang Songbai
Yichang maternal and child Health care Hospital
Outcome results
None listed